Overview
Investment committees and BD teams need independent, unbiased market intelligence to evaluate assets with confidence. InsightAce provides investor-grade due diligence that verifies market size claims, benchmarks revenue projections, assesses competitive threats, and identifies regulatory risks — delivered as board-ready materials in 3–6 weeks.
What We Deliver
✓ Independent market size and growth validation
✓ Pipeline and clinical risk assessment
✓ Competitive threat and disruption analysis
✓ Revenue forecast benchmarking for investor materials
✓ Technology application and commercial viability assessment
✓ Deal tracking and partnership landscape analysis
✓ Regulatory risk assessment and pathway evaluation
✓ Risk-adjusted revenue projections
Our Methodology: InsightAce 360°
Every due diligence support engagement follows our InsightAce 360° framework: primary KOL research (15–25 interviews), secondary data triangulation, expert validation, and interactive strategy workshops. Deliverables include executive PowerPoint summaries, analyst-ready Excel workbooks, and dedicated post-delivery analyst hours.